Amdocs Revenues vs Net Income Analysis

DOX
 Stock
  

USD 88.95  1.36  1.55%   

Amdocs financial indicator trend analysis is way more than just evaluating Amdocs Limited prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs Limited is a good investment. Please check the relationship between Amdocs Revenues and its Net Income accounts. Continue to Investing Opportunities.

Revenues vs Net Income

Revenues vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Limited Revenues account and Net Income. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Amdocs' Revenues and Net Income is 0.88. Overlapping area represents the amount of variation of Revenues that can explain the historical movement of Net Income in the same time period over historical financial statements of Amdocs Limited, assuming nothing else is changed. The correlation between historical values of Amdocs' Revenues and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Revenues of Amdocs Limited are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Revenues i.e., Amdocs' Revenues and Net Income go up and down completely randomly.

Correlation Coefficient

0.88
Relationship DirectionPositive 
Relationship StrengthStrong

Revenues

Revenues refers to the total amount of money received by Amdocs for goods sold or services provided during a certain time period. It also includes all of Amdocs Limited sales as well as any other increase in Amdocs Limited equity.Revenues are reported on Amdocs Limited income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Amdocs Limited financial statement analysis. It represents the amount of money remaining after all of Amdocs Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.
Most indicators from Amdocs fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Investing Opportunities.Amdocs Net Cash Flow Business Acquisitions and Disposals is fairly stable at the moment as compared to the past year. Amdocs reported Net Cash Flow Business Acquisitions and Disposals of 168.24 Million in 2021. Enterprise Value over EBIT is likely to rise to 15.21 in 2022, whereas Selling General and Administrative Expense is likely to drop slightly above 557.8 M in 2022.
 2019 2020 2021 2022 (projected)
Consolidated Income497.84 M688.37 M791.63 M673.75 M
Direct Expenses2.76 B2.81 B2.53 B2.34 B

Amdocs fundamental ratios Correlations

0.150.24-0.550.44-0.80.71-0.380.06-0.220.330.550.160.310.050.030.290.79-0.66-0.79
0.15-0.29-0.66-0.15-0.550.10.090.04-0.26-0.21-0.11-0.33-0.18-0.26-0.05-0.160.150.25-0.12
0.24-0.29-0.30.96-0.30.66-0.9-0.870.740.930.930.980.80.940.860.960.7-0.6-0.49
-0.55-0.66-0.3-0.50.94-0.70.460.340.01-0.33-0.53-0.24-0.21-0.26-0.33-0.44-0.680.160.73
0.44-0.150.96-0.5-0.530.8-0.92-0.80.620.890.980.940.750.890.810.960.81-0.63-0.65
-0.8-0.55-0.30.94-0.53-0.790.480.220.1-0.37-0.6-0.23-0.28-0.2-0.25-0.43-0.80.380.81
0.710.10.66-0.70.8-0.79-0.75-0.480.110.710.820.580.450.580.50.740.87-0.58-0.79
-0.380.09-0.90.46-0.920.48-0.750.85-0.67-0.86-0.88-0.87-0.69-0.86-0.91-0.91-0.780.510.56
0.060.04-0.870.34-0.80.22-0.480.85-0.85-0.85-0.74-0.84-0.73-0.87-0.96-0.83-0.550.320.31
-0.22-0.260.740.010.620.10.11-0.67-0.850.620.560.780.720.730.860.640.26-0.28-0.08
0.33-0.210.93-0.330.89-0.370.71-0.86-0.850.620.910.840.860.810.790.860.8-0.69-0.59
0.55-0.110.93-0.530.98-0.60.82-0.88-0.740.560.910.870.830.810.740.910.88-0.73-0.75
0.16-0.330.98-0.240.94-0.230.58-0.87-0.840.780.840.870.730.960.860.950.59-0.51-0.39
0.31-0.180.8-0.210.75-0.280.45-0.69-0.730.720.860.830.730.630.690.680.71-0.76-0.56
0.05-0.260.94-0.260.89-0.20.58-0.86-0.870.730.810.810.960.630.880.970.52-0.36-0.3
0.03-0.050.86-0.330.81-0.250.5-0.91-0.960.860.790.740.860.690.880.860.54-0.32-0.32
0.29-0.160.96-0.440.96-0.430.74-0.91-0.830.640.860.910.950.680.970.860.71-0.49-0.5
0.790.150.7-0.680.81-0.80.87-0.78-0.550.260.80.880.590.710.520.540.71-0.73-0.85
-0.660.25-0.60.16-0.630.38-0.580.510.32-0.28-0.69-0.73-0.51-0.76-0.36-0.32-0.49-0.730.67
-0.79-0.12-0.490.73-0.650.81-0.790.560.31-0.08-0.59-0.75-0.39-0.56-0.3-0.32-0.5-0.850.67
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

201720182019202020212022 (projected)
Receivables971.5 M987.86 M861.03 M866.82 M780.14 M737.36 M
Accounts Payable194.74 M176.51 M110.14 M121.2 M139.38 M156.14 M
Accumulated Other Comprehensive Income18.79 M(32.73 M)(2.55 M)11.66 M13.41 M14.47 M
Total Assets5.35 B5.29 B6.34 B6.51 B7.49 B7.04 B
Current Assets1.72 B1.68 B2.07 B2.07 B1.86 B1.85 B
Assets Non Current3.63 B3.62 B4.27 B4.44 B5.11 B4.59 B
Cash and Equivalents519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Cash and Equivalents USD519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Deferred Revenue132.41 M118.18 M126.84 M237.37 M272.98 M233.37 M
Shareholders Equity3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Shareholders Equity USD3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Goodwill and Intangible Assets2.71 B2.67 B2.87 B2.88 B3.31 B3.12 B
Total Liabilities1.86 B1.75 B2.68 B2.88 B3.31 B2.86 B
Current Liabilities1.29 B1.21 B1.22 B1.3 B1.5 B1.49 B
Liabilities Non Current560.82 M542.43 M1.46 B1.57 B1.81 B1.95 B
Trade and Non Trade Payables194.74 M176.51 M110.14 M1.01 B1.16 B1.25 B
Property Plant and Equipment Net496.58 M525.31 M903.45 M931.93 M1.07 B1.16 B
Trade and Non Trade Receivables971.5 M987.86 M861.03 M866.82 M996.84 M984.27 M
Accumulated Retained Earnings Deficit4.67 B5.01 B5.34 B5.85 B6.73 B5.93 B
Tax Liabilities219.42 M224.57 M207.51 M258.49 M232.64 M240.95 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.089
Market Capitalization
10.8 B
Quarterly Revenue Growth YOY
0.088
Return On Assets
0.0605
Return On Equity
0.15
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.